PDE3A and glioblastoma: Velcrin treatment led to a significant reduction in nascent polypeptide formation in velcrin-sensitive glioblastoma cell lines GB1, DBTRG-05MG, and NP5, but not in GB1 PDE3A KO cells (Figure 3A and B).